Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mixed Dyslipidemias”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01216956
What this trial is testing

Metabolic Effects of an 8 Week Niaspan Treatment in Patients With Abdominal Obesity and Mixed Dyslipidemia

Who this might be right for
Insulin SensitivityLipoproteins MetabolismNon Esterified Fatty Acid Kinetics+1 more
Centre de Recherche en Nutrition Humaine Rhone-Alpe 24
Not applicableEnded earlyNCT01228019
What this trial is testing

Niacin (+) Laropiprant (TREDAPTIVE) Re-examination Study (MK-0524A-119)

Who this might be right for
HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,166
Not applicableStudy completedNCT04063137
What this trial is testing

Black Rice Anthocyanin in Mixed Meals: Influence on Postprandial Glycaemic and Lipid Responses Among Healthy Individuals

Who this might be right for
Postprandial HyperglycemiaLipidemia
National University of Singapore 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT07474649
What this trial is testing

Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events

Who this might be right for
Coronary AtherosclerosisMixed DyslipidemiaHypercholesterolemia
Daiichi Sankyo 103
Not applicableLooking for participantsNCT06752772
What this trial is testing

WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study

Who this might be right for
Elevated Blood PressureHypertensionOverweight/Obesity+3 more
Alexandra Hospital 1,700
Large-scale testing (Phase 3)Study completedNCT00300456
What this trial is testing

Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood

Who this might be right for
DyslipidemiaCoronary Heart DiseaseMixed Dyslipidemia
Abbott 657
Post-approval studies (Phase 4)Study completedNCT00754039
What this trial is testing

Study to Compare Welchol and TriCor to TriCor Alone in Patients With High Cholesterol

Who this might be right for
HypercholesterolemiaHyperlipidemia, Familial Combined
Daiichi Sankyo 129
Large-scale testing (Phase 3)Study completedNCT00349375
What this trial is testing

Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 1,040
Large-scale testing (Phase 3)Study completedNCT05260411
What this trial is testing

Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 246
Large-scale testing (Phase 3)Ended earlyNCT01274559
What this trial is testing

Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Merck Sharp & Dohme LLC 1,173
Large-scale testing (Phase 3)Study completedNCT00362206
What this trial is testing

Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin

Who this might be right for
Hyperlipidemia
Solvay Pharmaceuticals 423
Large-scale testing (Phase 3)Study completedNCT05255458
What this trial is testing

Evaluate the Long-term Efficacy and Safety of AK102 in Patients With Hyperlipidemia

Who this might be right for
Hyperlipidemia
Akeso 122
Large-scale testing (Phase 3)Active Not RecruitingNCT07473960
What this trial is testing

IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia

Who this might be right for
Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
Innovent Biologics (Suzhou) Co. Ltd. 198
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07592858
What this trial is testing

Use of Bile Acid Binding Resins to Decrease PFAS Levels Via Colesevalem in Veterans Study

Who this might be right for
PFASEnvironmental ExposuresOccupational Exposure to Chemicals+5 more
University of Rhode Island 50
Large-scale testing (Phase 3)Study completedNCT01879319
What this trial is testing

Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen

Who this might be right for
Primary HypercholesterolemiaMixed Dyslipidemia
Amgen 164
Large-scale testing (Phase 3)Study completedNCT04849000
What this trial is testing

Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage

Who this might be right for
Primary HypercholesterolemiaMixed Hyperlipemia
Jiangsu HengRui Medicine Co., Ltd. 709
Large-scale testing (Phase 3)Looking for participantsNCT07614958
What this trial is testing

Phase 3 Clinical Study Evaluating Efficacy, Safety, and Tolerability of Obicetrapib Vs Bempedoic Acid to Treat Dyslipidemia in Adults With Primary Non-familial Hypercholesterolemia or Mixed Dyslipidemia at High to Very High Cardiovascular Risk, During a Treatment Period of Approximately 84 Days

Who this might be right for
Mixed DyslipidemiaHypercholesterolaemia
A. Menarini International Licensing S.A. 426
Not applicableStudy completedNCT01245738
What this trial is testing

Effect of Statins on Lipid Levels Following the First Acute Coronary Event (MK-0000-204)

Who this might be right for
DyslipidemiasHypercholesterolemiaHypertriglyceridemia+2 more
Merck Sharp & Dohme LLC 635
Large-scale testing (Phase 3)Study completedNCT02548832
What this trial is testing

Bezafibrate Plus Berberine in Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
University of Guadalajara 36
Large-scale testing (Phase 3)Study completedNCT00491530
What this trial is testing

A Year 2, Safety Extension Study of the Combination of ABT-335 and Statin Therapy for Subjects With Mixed Dyslipidemia

Who this might be right for
Mixed Dyslipidemia
Abbott 310
Next Page